Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Watching INSM and ASTM ticking up right now +5-6%
DNDN and CEGE bidding up a little pre-market
MO ticking up again gotta love it.
ESLR ticking up a bit Pre-market
MO.....you out now are waiting for more?????
CEGE selling off
DNDN ?? Volume picking up and back above $15
DNDN jumping here
ESLR showing a little strength EOD
DNDN trying to stay green
MSFT...nice little move for the monster today. I know its not a huge % move but it bodes well for tech. IMHO
FCEL....I agree hell of a call.
FCEL getting pounded today
FSLR looking good as well
ESLR having a nice little day
GNTA +6%
Watch GNTA today had some news this AM.
NUVO ticking up a bit of news.......
Nuvelo Announces Presentation on NU206 at 2007 American Association for Cancer Research Annual Meeting
Apr 4, 2007 09:00:00 (ET)
SAN CARLOS, Calif., April 4, 2007 /PRNewswire-FirstCall via COMTEX/ -- Nuvelo, Inc. (NUVO, Trade ) today announced that preclinical data evaluating the mechanism of action and role of NU206 (R-Spondin1) as a specific and potent stimulator of the gastrointestinal (GI) epithelial cells will be presented in an educational session at the 2007 American Association for Cancer Research (AACR) Annual Meeting taking place at the Los Angeles Convention Center in Los Angeles, CA, April 14-18, 2007.
The presentation details are as follows:
Date/Time: Saturday, April 14, 2007, 8:00-10:00 a.m. PDT
Location: Room 403 A-B, Los Angeles Convention Center
Session/Abstract Title: Therapeutic Cancer Targets in the Wnt
Pathway/R-Spondin, novel regulators of the Wnt/b-catenin signaling
About NU206
NU206, also known as human R-spondin1, is a recombinant, secreted protein that has the potential to act as a potent and highly specific growth factor of GI epithelial cells. In early animal model studies, NU206 promoted growth and repair of these tissues in models of radiation treatment or chemotherapy, as well as in animal models of inflammatory bowel disease and short bowel syndrome. A publication in the August 2005 issue of Science described results from studies in animal models of mucositis, where NU206 was shown to diminish symptoms of mucositis, including diarrhea and weight loss.
About Nuvelo and Kirin's Joint Collaborative Effort
Scientists from Nuvelo and Kirin worked together to identify and characterize NU206 as part of a collaboration focused on the discovery of novel, secreted proteins. NU206 is the first compound to enter preclinical studies from this program. Nuvelo signed a collaboration agreement with Kirin in April 2005 to develop NU206. Under the agreement, Nuvelo leads worldwide development, manufacturing and commercialization and all operating expenses and profits related to the development and commercialization of NU206 are shared 60% (Nuvelo)/40% (Kirin).
About Nuvelo
Nuvelo, Inc. is dedicated to improving the lives of patients through the discovery, development and commercialization of novel drugs for acute cardiovascular and cancer therapy. Nuvelo's development pipeline includes three acute cardiovascular programs: alfimeprase, a direct-acting thrombolytic for the treatment of thrombotic-related disorders which is suspended pending review and analysis of clinical data; rNAPc2, an anticoagulant that inhibits the factor VIIa and tissue factor protease complex that completed Phase 2 clinical development in acute coronary syndromes; and preclinical candidate NU172, a direct thrombin inhibitor for use as a short-acting anticoagulant during medical or surgical procedures. Nuvelo is also advancing an emerging oncology pipeline, including rNAPc2 which is in Phase 2 testing for potential use as a cancer therapy, as well as NU206 a preclinical candidate for the potential treatment of chemotherapy/radiation therapy-induced mucositis and inflammatory bowel disease. In addition, Nuvelo expects to leverage its expertise in secreted proteins and cancer antibody discovery to further expand its pipeline and create additional partnering and licensing opportunities.
Information about Nuvelo is available at our website at www.nuvelo.com or by phoning 650-517-8000.
About Kirin
Kirin Brewery's Pharmaceutical Division is committed to providing innovative pharmaceuticals to patients in the field of kidney diseases, cancer (including hematological disorders), immunological diseases, and infectious diseases by using its unique and strong biotechnology. Kirin Brewery's Pharmaceutical Division has established operations in Asian countries and will expand globally including North America and Europe as a specialty pharmaceutical company. For more information on Kirin Brewery's Pharmaceutical Division, please visit its website at http://www.kirin.co.jp/english/index.html .
This press release contains "forward-looking statements," which include statements regarding the potential uses of NU206 to treat various conditions, the timing and progress of Nuvelo's clinical stage and preclinical research programs, and the potential utility of other Nuvelo compounds to treat particular indications, which statements are hereby identified as "forward-looking statements" for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Such statements are based on our management's current expectations and involve risks and uncertainties. Actual results and performance could differ materially from those projected in the forward-looking statements as a result of many factors, including, without limitation, uncertainties relating to drug discovery; clinical development processes; enrollment rates for patients in our clinical trials; and dependence upon strategic partners for the performance of critical activities under collaborative agreements. These and other factors are identified and described in more detail in Nuvelo filings with the SEC, including without limitation Nuvelo's Annual Report on Form 10-K for the year ended December 31, 2006 and subsequent filings. We disclaim any intent or obligation to update these forward-looking statements.
SOURCE Nuvelo, Inc.
Shelly Guyer of VP of Business Development & IR, +1-650-517- 8437, or
sguyer@nuvelo.com, for Nuvelo; or Danielle Bertrand of WeissComm Partners, Inc.,
+1-415-946-1056, or dbertrand@weisscommpartners.com, for Nuvelo
http://www.nuvelo.com/
KRY & DNDN ticking up Pre-Market
DNDN 15.05 X 15.08 PRE- MARKET
KRY news...
Crystallex Hires Chief Operating Officer and Senior Vice President
Apr 3, 2007 14:43:31 (ET)
TORONTO, ONTARIO, Apr 03, 2007 (MARKET WIRE via COMTEX) -- Crystallex International Corporation (KRY, Trade ) announced today the appointment of William A. Faust as Chief Operating Officer and Senior Vice President, effective April 16, 2007. Mr. Faust will direct the Company's mining operations in Venezuela, including the development, construction and operation of the Las Cristinas gold project located in Bolivar State, Venezuela.
Mr. Faust has over 28 years of engineering and management experience, particularly in open pit mining in Mexico and the Western U.S.
Mr. Faust most recently served as Vice President Operations for Nevada Pacific Gold Ltd., which was acquired by US Gold Corporation in March 2007. Prior to his tenure at Nevada Pacific Gold, he was President of Pan American Silver's Mexican operations, in charge of expanding the La Colorada underground silver mine in Zacatecas. He was also Vice President, Operations from 2001 to 2003 of Corner Bay Silver Inc. prior that company's sale to Pan American Silver Inc. where Mr. Faust was in charge of developing a new open pit silver mine in Sonora, Mexico.
As Vice President Operations of Eldorado Gold Corporation from 1997 to 2001, Mr. Faust was in charge of two operating mines in Mexico and Brazil, with over 700 employees and 14 contractors with 250 employees producing 180,000 ounces of gold annually. He was also involved in project evaluations and feasibility studies at Eldorado Gold. Previously Mr. Faust worked as Manager of Engineering for Santa Fe Pacific Gold Corporation in project evaluation and development roles, after serving as Mine Manager at the Twin Creeks Mine in Nevada. Prior to that, he worked for Gold Fields Mining Company as Mine Operations Manager at the Chimney Creek Mine in Nevada, where he joined the project at the feasibility study stage as Chief Engineer, and saw the mine through construction and commissioning.
Mr. Faust is a Registered Professional Engineer in New Mexico, and holds an MBA Finance, Management from Western New Mexico University, a BS, Mining Engineering from New Mexico Tech, and a BS, Civil Engineering from the University of New Mexico, and is fluent in Spanish.
Commenting on Mr. Faust's appointment Mr. Gordon Thompson, Crystallex President and CEO said, "Bill's experience in building and operating mining projects in Latin America is a strategic match for Crystallex's operations, both existing and planned, in Venezuela. We are very pleased to welcome him to the team."
Crystallex is in the final stages of environmental permitting for the Las Cristinas project.
About Crystallex
Crystallex International Corporation is a Canadian based gold producer with significant operations and exploration properties in Venezuela. The Company's principal asset is the Las Cristinas property in Bolivar State that is currently under development and which is expected to commence commercial gold production in 2009 at an initial annualized rate of some 300,000 ounces at the initial planned production rate of 20,000 tonnes of ore per day. Other key assets include the Tomi Mine, certain Lo Increible properties and the Revemin Mill. Crystallex shares trade on the TSX (symbol:KRY) and AMEX (symbol:KRY) Exchanges.
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws, including: statements relating to the estimated reserves and resources at Las Cristinas; anticipated results of drilling programs, feasibility studies or other analyses; the potential to increase reserves and expand production, at Las Cristinas; Crystallex's projected construction and production schedule, and cost and production estimates, for Las Cristinas; and management's statements regarding its expectations regarding mining in Venezuela. Forward-looking statements are based on estimates and assumptions made by Crystallex in light of its experience and perception of historical trends, current conditions and expected future developments, as well as other factors that Crystallex believes are appropriate in the circumstances. Many factors could cause Crystallex's actual results, performance or achievements to differ materially from those expressed or implied by the forward looking statements, including: gold price volatility; impact of any hedging activities, including margin limits and margin calls; discrepancies between actual and estimated production, between actual and estimated reserves, and between actual and estimated metallurgical recoveries; mining operational risk; regulatory restrictions, including environmental regulatory restrictions and liability; risks of sovereign investment; speculative nature of gold exploration; dilution; competition; loss of key employees; additional funding requirements; and defective title to mineral claims or property. These factors and others that could affect Crystallex's forward-looking statements are discussed in greater detail in the section entitled "Risk Factors" in Crystallex's Annual Information Form (which is included in the Annual Report on Form 40-F that Crystallex files with the United States Securities and Exchange Commission (the "SEC") and elsewhere in documents filed from time to time with the Canadian provincial securities regulators, the SEC and other regulatory authorities. These factors should be considered carefully, and persons reviewing this press release should not place undue reliance on forward-looking statements. Crystallex has no intention and undertakes no obligation to update or revise any forward-looking statements in this press release, except as required by law.
Contacts:
Crystallex International Corporation
Investor Relations Contact
Richard Marshall, VP
1-800-738-1577
Email: info@crystallex.com
Website:
www.crystallex.com
KRY news....
Crystallex Hires Chief Operating Officer and Senior Vice President
Apr 3, 2007 14:43:31 (ET)
TORONTO, ONTARIO, Apr 03, 2007 (MARKET WIRE via COMTEX) -- Crystallex International Corporation (KRY, Trade ) announced today the appointment of William A. Faust as Chief Operating Officer and Senior Vice President, effective April 16, 2007. Mr. Faust will direct the Company's mining operations in Venezuela, including the development, construction and operation of the Las Cristinas gold project located in Bolivar State, Venezuela.
Mr. Faust has over 28 years of engineering and management experience, particularly in open pit mining in Mexico and the Western U.S.
Mr. Faust most recently served as Vice President Operations for Nevada Pacific Gold Ltd., which was acquired by US Gold Corporation in March 2007. Prior to his tenure at Nevada Pacific Gold, he was President of Pan American Silver's Mexican operations, in charge of expanding the La Colorada underground silver mine in Zacatecas. He was also Vice President, Operations from 2001 to 2003 of Corner Bay Silver Inc. prior that company's sale to Pan American Silver Inc. where Mr. Faust was in charge of developing a new open pit silver mine in Sonora, Mexico.
As Vice President Operations of Eldorado Gold Corporation from 1997 to 2001, Mr. Faust was in charge of two operating mines in Mexico and Brazil, with over 700 employees and 14 contractors with 250 employees producing 180,000 ounces of gold annually. He was also involved in project evaluations and feasibility studies at Eldorado Gold. Previously Mr. Faust worked as Manager of Engineering for Santa Fe Pacific Gold Corporation in project evaluation and development roles, after serving as Mine Manager at the Twin Creeks Mine in Nevada. Prior to that, he worked for Gold Fields Mining Company as Mine Operations Manager at the Chimney Creek Mine in Nevada, where he joined the project at the feasibility study stage as Chief Engineer, and saw the mine through construction and commissioning.
Mr. Faust is a Registered Professional Engineer in New Mexico, and holds an MBA Finance, Management from Western New Mexico University, a BS, Mining Engineering from New Mexico Tech, and a BS, Civil Engineering from the University of New Mexico, and is fluent in Spanish.
Commenting on Mr. Faust's appointment Mr. Gordon Thompson, Crystallex President and CEO said, "Bill's experience in building and operating mining projects in Latin America is a strategic match for Crystallex's operations, both existing and planned, in Venezuela. We are very pleased to welcome him to the team."
Crystallex is in the final stages of environmental permitting for the Las Cristinas project.
About Crystallex
Crystallex International Corporation is a Canadian based gold producer with significant operations and exploration properties in Venezuela. The Company's principal asset is the Las Cristinas property in Bolivar State that is currently under development and which is expected to commence commercial gold production in 2009 at an initial annualized rate of some 300,000 ounces at the initial planned production rate of 20,000 tonnes of ore per day. Other key assets include the Tomi Mine, certain Lo Increible properties and the Revemin Mill. Crystallex shares trade on the TSX (symbol:KRY) and AMEX (symbol:KRY) Exchanges.
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws, including: statements relating to the estimated reserves and resources at Las Cristinas; anticipated results of drilling programs, feasibility studies or other analyses; the potential to increase reserves and expand production, at Las Cristinas; Crystallex's projected construction and production schedule, and cost and production estimates, for Las Cristinas; and management's statements regarding its expectations regarding mining in Venezuela. Forward-looking statements are based on estimates and assumptions made by Crystallex in light of its experience and perception of historical trends, current conditions and expected future developments, as well as other factors that Crystallex believes are appropriate in the circumstances. Many factors could cause Crystallex's actual results, performance or achievements to differ materially from those expressed or implied by the forward looking statements, including: gold price volatility; impact of any hedging activities, including margin limits and margin calls; discrepancies between actual and estimated production, between actual and estimated reserves, and between actual and estimated metallurgical recoveries; mining operational risk; regulatory restrictions, including environmental regulatory restrictions and liability; risks of sovereign investment; speculative nature of gold exploration; dilution; competition; loss of key employees; additional funding requirements; and defective title to mineral claims or property. These factors and others that could affect Crystallex's forward-looking statements are discussed in greater detail in the section entitled "Risk Factors" in Crystallex's Annual Information Form (which is included in the Annual Report on Form 40-F that Crystallex files with the United States Securities and Exchange Commission (the "SEC") and elsewhere in documents filed from time to time with the Canadian provincial securities regulators, the SEC and other regulatory authorities. These factors should be considered carefully, and persons reviewing this press release should not place undue reliance on forward-looking statements. Crystallex has no intention and undertakes no obligation to update or revise any forward-looking statements in this press release, except as required by law.
Contacts:
Crystallex International Corporation
Investor Relations Contact
Richard Marshall, VP
1-800-738-1577
Email: info@crystallex.com
Website:
www.crystallex.com
DNDN....Its amazing that its stronger today then ESLR with the kind of news they had. I guess it just goes to show what kind of money DNDN could be printing if they get there go ahead. Read an article that put there yearly sales at $1 billion with this drug....SICK.....all MHO of course.
DNDN monster 15.10
DNDN $15
DNDN on the move.
RIO, PCU....If any play bigger fish take a look at those moves.
DNDN looking strong here....been a nice little ride. Stem cells giving back gains today. ESLR looking good.
Thanks.....ESLR 10.50 x 10.57 right now
LOOKS LIKE A GOOD DAY......IMHO
ESLR...Might see a move today Yahoo shows 30% short position......
Share Statistics
Average Volume (3 month)3: 3,011,810
Average Volume (10 day)3: 2,412,390
Shares Outstanding: 69.25M
Float: 68.05M
% Held by Insiders4: 31.16%
% Held by Institutions4: 67.20%
Shares Short (as of 12-Mar-07)3: 20.47M
Short Ratio (as of 12-Mar-07)3: 5.6
Short % of Float (as of 12-Mar-07)3: 30.50%
Shares Short (prior month)3: 18.43M
ESLR...Might see a move today Yahoo shows 30% short position......
Share Statistics
Average Volume (3 month)3: 3,011,810
Average Volume (10 day)3: 2,412,390
Shares Outstanding: 69.25M
Float: 68.05M
% Held by Insiders4: 31.16%
% Held by Institutions4: 67.20%
Shares Short (as of 12-Mar-07)3: 20.47M
Short Ratio (as of 12-Mar-07)3: 5.6
Short % of Float (as of 12-Mar-07)3: 30.50%
Shares Short (prior month)3: 18.43M
ESLR...Might see a move today Yahoo shows 30% short position......
Share Statistics
Average Volume (3 month)3: 3,011,810
Average Volume (10 day)3: 2,412,390
Shares Outstanding: 69.25M
Float: 68.05M
% Held by Insiders4: 31.16%
% Held by Institutions4: 67.20%
Shares Short (as of 12-Mar-07)3: 20.47M
Short Ratio (as of 12-Mar-07)3: 5.6
Short % of Float (as of 12-Mar-07)3: 30.50%
Shares Short (prior month)3: 18.43M
ESLR...Might see a move today Yahoo shows 30% short position......
Share Statistics
Average Volume (3 month)3: 3,011,810
Average Volume (10 day)3: 2,412,390
Shares Outstanding: 69.25M
Float: 68.05M
% Held by Insiders4: 31.16%
% Held by Institutions4: 67.20%
Shares Short (as of 12-Mar-07)3: 20.47M
Short Ratio (as of 12-Mar-07)3: 5.6
Short % of Float (as of 12-Mar-07)3: 30.50%
Shares Short (prior month)3: 18.43M
Looks Like DNDN bidding up again this morning 14.60 x 14.65 right now
I've owned them a long time......not a master traded by any stretch ASTM,STEM, and GERN I've owned and added to whenever I could. When i saw all three begin climbing this morning I added a bit more ASTM. I think they will start moving twords the elections next year. IMHO
what a move by FSLR today that BOA upgrade lit them all up STP, ZOLT.....etc.
Paul picked up ASTM this morning also +12%
STEM.......
Share Statistics
Average Volume (3 month)3: 1,639,140
Average Volume (10 day)3: 958,867
Shares Outstanding: 78.63M
Float: 77.44M
% Held by Insiders4: 1.69%
% Held by Institutions4: 8.00%
Shares Short (as of 12-Mar-07)3: 4.13M
Short Ratio (as of 12-Mar-07)3: 4.2
Short % of Float (as of 12-Mar-07)3: 5.30%
Shares Short (prior month)3: 3.24M
STEM....wow what a move into the close